STE - CIK 0001757898
The table below shows STERIS plc's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $1.15B | $973.27M | $756.95M | $684.81M | $689.64M | $590.56M |
| Capital expenditure | $370.09M | $360.33M | $361.97M | $287.56M | $239.26M | $214.52M |
| Investing cash flow | $388.77M | -$887.36M | -$383.33M | -$666.56M | -$1.15B | -$319.74M |
| Dividends paid | $219.88M | $200.57M | $183.50M | $163.17M | $133.84M |
STERIS plc reported operating cash flow of $1.15B for fiscal year 2025. That is up 18.0% from $973.27M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow grew from $424.09M (FY 2017) to $1.15B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $123.03M |
| Stock buybacks | $211.32M | $11.77M | $308.56M | $55.78M | $14.65M | $51.24M |
| Financing cash flow | -$1.57B | -$85.19M | -$498.72M | $115.83M | $345.62M | -$163.15M |